BLyS^-/- significantly decreased IgM and IgG secreting cells. by Natalie M. Bath (6316517)

Subjects:

Nitrate and nitrite treatment did not adversely affect multiple parameters of health but nitrate treatment significantly decreased movement following a startle. by Manuel García-Jaramillo (9930572)

Mucosal bacteria differentially affect neutrophil lifespan. by Tiffany Hensley-McBain (4872715)

Percentage of new cases of domestic vector-borne diseases by age group and sex in the pre- and post-COVID-19 pandemic periods. by Kenji Hibiya (96281)

Subjects:

Decrease of injuries. by Petr Fulin (8380320)

Subjects:

Decreasing laminin levels in BCs does not affect their migration. by Ester Molina López (16462735)

Networks of affect states: Significant paths. by Anna Kuranova (8460411)

“…<p>In this figure, affect states networks are visualized for the Stable and the Increase groups. …”

Summary of post-operative characteristics including post-operative complications, Clavien-Dindo score, and post-operative histopathology. by Aiman Aslam (15213610)

Percentage of treated cattle pregnant in relation to anti-GnRH antibody titres across all years post-booster. by Rebecca Pinkham (13262098)

Subjects:

The variation trend of |BD| value with age: With the increase of age, the |BD| values decreased significantly (p<0.01). by Yunmeng Da (707943)

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)

“…<p>Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts.…”

Decreased virulence observed during <i>in planta</i> infection with <i>ΔFgknr4</i>. by Erika Kroll (20537020)

“…Letters indicate significant differences (ANOVA, TukeyHSD <i>p</i> < 0.05).…”

APRIL^-/- and BLyS^-/- lymphocyte proliferation significantly decreased when challenged with alloantigen. by Natalie M. Bath (6316517)

Subjects:

Socio-demographic and medical characteristics of patients with liver cancer. by Ayana Ablayeva (22103708)

Subjects:

Data cleaning and preparation algorithm. by Ayana Ablayeva (22103708)

Subjects:

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

Subjects:

Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. by Ayana Ablayeva (22103708)

Subjects:

Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects: